Showing 1191-1200 of 6663 results for "".
ISDPA: Dr. Bhatia and Dr. Zirwas Discuss the Itchy Patient
https://practicaldermatology.com/conferences/isdpa-midwest-derm-2024/isdpa-dr-bhatia-and-dr-zirwas-discuss-itchy-patient/27065/Practical Dermatology Chief Medical Editor Neal Bhatia, MD, FAAD, talks with Matthew Zirwas, MD, about Dr. Zirwas’s lecture on the itchy patient and the latest solutions for itch at the Illinois Society of Dermatology Physician Assistants (ISDPA) Midwest Dermatology Conference 2024.Rosacea and Beyond: PDT Patient Success Stories
https://practicaldermatology.com/topics/skin-cancer-photoprotection/rosacea-and-beyond-pdt-patient-success-stories/20214/Dr. Jill S. Waibel, a Miami dermatologist specializing in laser surgery, cosmetic dermatology, and medical dermatology, shares success stories using photodynamic therapy (PDT) and provides techniques and tips for optimal patient results. Dr. Waibel is a world-recognized leader and innovator in dermaRecap of Maui Derm Hawaii Meeting
https://practicaldermatology.com/series/dermwire-tv/recap-of-maui-derm-hawaii-meeting/32717/In this week's DermwireTV, key stakeholders in dermatology gather in Hawaii to discuss the latest developments and advances; a new review examines whether IgE-targeting therapies could represent a new treatment avenue for psoriasis and atherosclerosis; and the founder of SEEN hair care joSDPA: Dr. Matthew Zirwas Discusses Benefits of Attending the Annual Conference
https://practicaldermatology.com/conferences/sdpa-2024/sdpa-dr-matthew-zirwas-discusses-benefits-of-attending-the-annual-conference/29510/At the SDPA 22nd Annual Fall Dermatology Conference, Practical Dermatology caught up with Matthew Zirwas, MD. Dr. Zirwas shares why he looks forward to lecturing at the annual meeting.FDA Approves Rosacea Treatment Emrosi
https://practicaldermatology.com/series/dermwire-tv/fda-approves-rosacea-treatment-emrosi/29207/In this week's DermwireTV, the FDA approves a first-of-its-kind treatment for rosacea in adults; two companies with approved atopic dermatitis products provide new long-term efficacy and safety data; and Andrew Mastro discusses how to recognize physician burnout.Significant FDA Approval for PDT
https://practicaldermatology.com/series/pdt-in-practice/significant-fda-approval-pdt/29102/Dr. Jonathan S. Weiss discusses the importance of a recent FDA approval involving dosing of a PDT photosensitizer for both lesion-directed and field-directed treatment of actinic keratosis.Hair Regrowth and Choosing Your Device
https://practicaldermatology.com/series/pdt-in-practice/hair-regrowth-and-choosing-your-device/26994/Dr. Hamza D. Bhatti, a board-certified dermatologist and dually accredited fellowship-trained Mohs micrographic surgeon and cosmetic dermatologic surgeon, discusses utilizing red light photodynamic therapy (PDT) for hair regrowth with androgenic alopecia, as well as key considerations when selectingExciting Developments in Treating Pediatric Dermatology
https://practicaldermatology.com/conferences/maui-derm-2024/exciting-developments-in-treating-pediatric-dermatology/20246/Chief Medical Editor Neal Bhatia, MD and Lawrence Eichenfield, MD, discuss the range of therapies currently approved or in the pipeline for atopic dermatitis, pruritus, pediatric acne--and the importance of messaging on TikTok.Welcome to the Decade of Eczema
https://practicaldermatology.com/topics/atopic-dermatitis/welcome-to-the-decade-of-eczema/20221/October is Eczema Awareness Month. Peter Lio, MD, discusses the wealth of available treatments for eczema and shares his excitement about the pipeline as part of the National Eczema Association’s new #OneThingAboutEczema campaign.Cosmetic Controversies: A CSF Update from the 2019 Meeting
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/cosmetic-controversies-a-csf-update/20121/Some of the leading minds in cosmetic surgery weigh in on the ongoing controversies in aesthetic patient care. David Goldberg, MD, JD, Zakia Rhaman, MD, Hema Sundaram, MD, and Julie Woodward, MD talk lasers, injectables, and influencers.